Huntington Beach, CA, United States of America

Christopher S Schaumburg

This inventor holds 8 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Allergan, Inc.. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher S Schaumburg. Retrieved from https://idiyas.com/inventor/christopher-s-schaumburg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 75.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Irvine, CA (US) (2012 - 2013)
Huntington Beach, CA (US) (2013 - 2018)

Company Filing History:

8 out of 2,287

Allergan, Inc.

patents

Years Active: 2012-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10065992 - Cyclosporin analogs (2018-09-04),

2. 9561259 - Cyclosporin analogs (2017-02-07),

3. 9493511 - Cyclosporin analogs (2016-11-15),

4. 9175042 - Cyclosporin analogs (2015-11-03),

5. 8821874 - KLK-13 antibody inhibitor for treating dry eye (2014-09-02),

6. 8491912 - Methods of treating ocular and other diseases with Syn-134R polypeptide (2013-07-23),

7. 8491905 - KLK-13 antibody inhibitor for treating dry eye (2013-07-23),

8. 8211434 - KLK-13 antibody inhibitor for treating dry eye (2012-07-03),

Title: The Innovative Contributions of Christopher S. Schaumburg

Introduction: Christopher S. Schaumburg, a notable inventor based in Huntington Beach, California, has made significant strides in the field of pharmaceuticals. With a total of eight patents to his name, Schaumburg's work focuses primarily on innovative treatments, particularly concerning dry eye conditions.

Latest Patents: Among his recent patents are several novel analogs of cyclosporin. These patents disclose pharmaceutical compositions that utilize these analogs and outline methods for their application in treating dry eye and other related conditions. The advancements brought forth by Schaumburg in this area aim to improve the quality of life for individuals suffering from these ailments.

Career Highlights: Schaumburg is affiliated with Allergan, Inc., a company renowned for its commitment to developing innovative medical solutions and addressing unmet needs in eye care and other therapeutic areas. Throughout his career, he has demonstrated a persistent dedication to pharmaceutical innovation.

Collaborations: Working alongside talented colleagues such as Michael E. Stern and Michael E. Garst, Schaumburg has contributed to a collaborative environment centered around groundbreaking research and development in the pharmaceutical industry.

Conclusion: Christopher S. Schaumburg's innovative contributions and patents highlight the potential for advancements in treating dry eye and other conditions. His dedication to research and collaboration at Allergan, Inc. stands as an inspiration for future inventors aiming to make a similar impact in healthcare and beyond.

Profile summary based on public USPTO records.